India: National Ethical Guidelines For Biomedical Research Involving Children: ICMR

Last Updated: 11 December 2017
Article by Singh & Associates

Most Read Contributor in India, December 2018

In October 2017, the first National Ethical Guidelines for Biomedical Research Involving Children has been published by the division of publication and information on behalf of the Secretary, Department of Health Research (DHR) & Director General (DG), Indian Council of Medical Research (ICMR), New Delhi.

Moreover, the latest version of "National Ethical Guidelines for Biomedical Research involving Human Participants, 2017" also has a section pertaining to research involving children. However, a need was felt to develop more comprehensive guidelines which pertain to the specifics of ethics in biomedical research involving children. Therefore, this endeavor was undertaken under the aegis of ICMR Advance Center for Newborn Health Research at All India Institute of Medical Sciences, New Delhi for the development of this guideline.

This Guideline will lead to advances in medical care which can potentially improve the health and quality of life of children and also counter the below listed queries and concerns-

Why biomedical research is necessary for children?

Here are some of the reasons, which support necessities of biomedical research in children:

  • There are some diseases which only affect children, and have no adult counterparts. Therefore, it is necessary to carry out research in children to advance the knowledge of these diseases. For example, hyaline membrane disease, birth asphyxia, neonatal hyperbilirubinemia, extrahepatic biliary atresia, infantile spasms, infantile tremor syndrome, Kawasaki disease, etc.
  • The physiology of children is different from that of adults, and the pharmacokinetics of many drugs is age-dependent based on the maturation of the drug metabolism pathways. For example, children metabolize many drugs much more rapidly as compared to adults.
  • The adverse effects of many drugs may also be different in children as compared to adults. For instance, Tetracycline causes teeth discoloration in young children and Aspirin use is associated with Reye's syndrome in children.
  • Age appropriate delivery vehicles and formulations (such as syrups) are needed for accurate, safe and palatable administration of medicines to infants and children.
  • The pathophysiology of many disorders is dependent on a child's growth, development and adaptive plasticity.
  • Research in children is also one of the ways to understand some adult diseases that are thought to have their origins in early life.

What are the challenges of biomedical research involving children?

Some challenges of biomedical research involving children:

  • Diseases in children may be rare, and there may not be sufficient numbers of affected patients to answer the research questions.
  • Difficult to find funding for research in children as the market for pediatric drugs and treatments is quite small compared to the adult ones.
  • The ethical concerns and obtaining informed consent of research involving children.
  • The familial and socio-cultural concerns are higher than individual patients while planning the research in children.
  • Research procedures and settings need to consider children's physical, cognitive, and emotional development.

What are the general guidelines for research involving children?

The following guidelines should be followed when conducting research in children:

  • Research proposals should be scientifically sound.
  • The equation between the potential benefit and the risk or potential harm should be at least as favorable for the proposed research procedure as for the alternatives available to the children.
  • There should be benefit to children in general and, in most cases, to the individual child subject.
  • The need for the study should be justified by a thorough review of literature.
  • The research should be conducted by a team of investigators who have the requisite expertise. One or more members of the team should be a paediatrician and/or have prior experience of conducting research involving children.
  • Research involving children should take into consideration the unique physiology, anatomy, psychology, pharmacology, social situation and special needs of children and their families.
  • Research involving children must be conducted in a child-friendly environment, as far as possible.
  • In general, drugs should be tested for safety, pharmacokinetics, and at least initial indications of efficacy in adults should be established before they are tested in children. It may often be appropriate to defer paediatric testing until adult testing has reached Phase III or beyond, when substantial data is available on the safety and efficacy of a drug in adults. However, there may be situations where studies involving children would be needed without prior adult studies, for example, Surfactant use in premature babies with respiratory distress syndrome.

How the consent or assent is obtained in research involving children?

The parental/ Legally Acceptable/ Authorized Representative (LARs) permission for the child's participation in the research is termed as 'consent', whereas the child's agreement to participate is termed as 'assent'. The consent or assent obtained by and/or behalf of children are -

  • Informed consent by parents/LAR: In research involving children, the traditional method of informed consent where decisions about research participation are made by those with the legal and intellectual capacity to make such choices for themselves, as children usually lack this capacity.
  • Informed consent by illiterate parents/LAR: When a participant is willing to participate but not willing to sign or give thumb impression or cannot do so, then verbal/oral consent may be taken on approval of the EC, in the presence of an impartial witness who should sign and date the document. This can be documented through audio or video recording of the participant, the PI and the impartial witness, all of whom should be captured in the frame.

Children assents:

  • For children less than 7 years of age, parental consent is sufficient.
  • For children between 7 (84 months and above) and 11 years of age, oral assent must be obtained in the presence of parent/LAR.
  • For children between 12 and 18 years of age, written assent must be obtained. If a child becomes 13 years old during the course of the study, then written assent must be obtained in addition to parent/LAR consent.
  • The process of re-consent/re-assent: In some cases, fresh or re-consent may need to be taken in case of new information becomes available which necessitates amendments in protocol, long term or study follow up extension, participants attain 18 year of age, treatment or protocol modalities etc.

What is Compensation in research involving children?

Compensation is two types:

  • Compensation for participation: The compensation is reimbursement of reasonable expenses incurred by child or caregivers to participate in research (for example, travel, wage loss). Children involved in research may also receive free medical services. The Ethics Committees have to ensure that payments do not act as inducements. Protocols should clearly mention the details about the type, level, and timing of payments to participants. The details should also be included in the informed consent form.
  • Compensation for Accidental Injury: Children are entitled to financial compensation and/or other assistance for any temporary or permanent impairment or disability resulting from participation in research. In the case of death, their parents are entitled to compensation.

What are special situations in research involving children?

There are various situations in research involving children where designing a research protocol needs consideration of ethics committee and subject expert committees such as -

  • Research in neonates
  • Research in HIV-positive children
  • Vaccine studies in children
  • Ethical issues in genetic research
  • Research involving children in an emergency situation
  • School-based research
  • Internet /Telephone-based research in children
  • Community-based Research in Children
  • Research involving adolescents (12-18 years)30.

NOTE- This document covers the ethical and legal issues that researchers need to consider when carrying out biomedical research in neonates and children. The aim is to set out general principles that can be applied in most situations rather than to cover every possible situation. These guidelines need to be used in conjunction with the current National Ethical Guidelines for Biomedical Research involving Human Participants, Indian Council of Medical Research (ICMR) Government of India and are meant for use by researchers, ethics committees and other involved stakeholders.



The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions